Tinavi Medical Technologies Co., Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
13.18
-0.78 (-5.59%)
Nov 17, 2026, 3:00 PM CST

SHA:688277 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-164.22-182.75-121.13-156.39-110.58-79.93
Depreciation & Amortization
42.9742.4939.3640.6144.5135.31
Other Amortization
7.616.613.644.115.656.3
Loss (Gain) From Sale of Assets
-0-0-5.64-00.01-
Asset Writedown & Restructuring Costs
0.050.050.260.030.740.42
Loss (Gain) From Sale of Investments
-3.4-3.4-40.4-56.22-0.1-3.57
Provision & Write-off of Bad Debts
-0.96-0.966.212.38-2.535.77
Other Operating Activities
-134.594.239.515.032.190.63
Change in Accounts Receivable
8.628.62-5.25-86.69-2.44-25.02
Change in Inventory
-20.52-16.45-5.5614.07-6.1-3.31
Change in Accounts Payable
-19.75-19.75-33.0626.9211.9720.18
Change in Other Net Operating Assets
72.7968.7331.8425.131-12.55
Operating Cash Flow
-169.97-51.17-98.65-170.5-87.51-77.76
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-29.57-29.71-36.69-221.03-59.59-238.66
Sale of Property, Plant & Equipment
-0.08-0.110.01--
Divestitures
46.2-5211.81--
Investment in Securities
96-45.559.61-49.5166.48127.73
Other Investing Activities
0.740.520.710.552.7312.2
Investing Cash Flow
113.28-74.775.74-258.179.62-98.73

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-58.4362.01201.1725-
Long-Term Debt Repaid
--63.14-83.9-27.94-22.94-28.91
Lease Payments
-2.21-2.21-5.09-13.23-22.44-28.91
Net Debt Issued (Repaid)
-12.25-4.72-21.89173.232.06-28.91
Issuance of Common Stock
49.2559.06-363.7-7.02
Common Dividends Paid
-6.52-7.18-9.06-4.68-0.76-
Other Financing Activities
-6.7257.2129.16-3.94-17.08
Financing Cash Flow
23.76104.37-1.79528.31.3-4.8

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.2-0.940.64-0.170.65-
Net Cash Flow
-34.13-22.43-24.0699.47-75.93-181.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-199.55-80.88-135.34-391.53-147.1-316.42
Free Cash Flow Growth
------
Free Cash Flow Margin
-74.49%-29.01%-75.68%-186.41%-94.18%-202.80%
Free Cash Flow Per Share
-0.44-0.18-0.30-0.88-0.35-0.75
Levered Free Cash Flow
-65.25-2.14-90.1-307.34-111.36-315.47
Unlevered Free Cash Flow
-60.975.46-84.38-303.32-108.89-313.38
Free Cash Flow After Leases
-201.75-83.09-140.43-404.76-169.54-345.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
54.755.54-4.3-4.852.71
Change in Working Capital
82.5782.579.54-10.06-27.39-42.7